Effect of alcohol on adipose tissue: A review on ethanol mediated adipose tissue injury

Adipocyte

Volumn 4, Issue 4, 2015, Pages 225-231

  Kema, Venkata Harini ^a   Mojerla, Nishank Reddy ^a   Khan, Imran ^a   Mandal, Palash ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Adipokines; Alcohol; Alcoholic liver disease; CYP2E1; Oxidative stress; White adipose tissue

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALCOHOL; ALCOHOL DEHYDROGENASE; CYTOCHROME P450 2E1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOPROTEIN PHOSPHATASE 2A; RETINOL BINDING PROTEIN 4; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE INJURY; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; BODY MASS; BROWN ADIPOSE TISSUE; CYTOKINE RELEASE; DISEASE COURSE; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HUMAN; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; TISSUE INJURY; WHITE ADIPOSE TISSUE;

EID: 85032842443     PISSN: 21623945     EISSN: 2162397X     Source Type: Journal    
DOI: 10.1080/21623945.2015.1017170     Document Type: Review

References (98)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2224-60.
2. Global status report on alcohol and health 2014; WHO Report.
3. Shield KD, Parry C, Rehm J. Chronic diseases and conditions related to alcohol use. Alcohol Res Curr Rev 2013; 35:155-71. PMID:24881324
4. Chen X, Sebastian BM, Tang H, McMullen MM, Axhemi A, Jacobsen DW, Nagy LE Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats. Hepatology 2009; 49(5):1554-62. PMID:19296466. http://dx.doi.org/10.1002/hep.22811
5. Mizoue T, Inoue M, Wakai K, Nagata C, Shimazu T, Tsuji I, Otani T, Tanaka K, Matsuo K, Tamakoshi A, et al. Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Am J Epidemiol 2008; 167:1397-406. PMID:18420544. http://dx.doi.org/10.1093/aje/kwn073
6. Yokoyama T, Yokoyama A, Kato H, Tsujinaka T, Muto M, Omori T, Haneda T, Kumagai Y, Igaki H, Yokoyama M, et al. Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol Biomarkers Prev 2003; 12:1227-33. PMID:14652286
7. Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med 2009; 6: e50. PMID:19320537
8. Hall P. Pathological spectrum of alcoholic liver disease. Alcoholic Liver Disease 1995; 2:41-88.
9. Lakshman MR. Some novel insights into the pathogenesis of alcoholic steatosis. Alcohol 2004; 34:45-8. PMID:15670665. http://dx.doi.org/10.1016/j.alcohol.2004.08.004
10. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011; 141:1572-85. PMID:21920463. http://dx.doi.org/10.1053/j.gastro.2011.09.002
11. Rogers CQ, Ajmo JM, You M. Adiponectin and alcoholic fatty liver disease. IUBMB Life 2008; 60:790-7. PMID:18709650. http://dx.doi.org/10.1002/iub.124
12. You M, Rogers CQ. Adiponectin: a key adipokine in alcoholic fatty liver. Exp Biol Med 2009; 234:850-9. PMID:19491377. http://dx.doi.org/10.3181/0902-MR-61
13. Saely CH, Geiger K, Drexel H. Brown versus white adipose tissue: a mini-review. Gerontology 2012; 58:15-23. PMID:21135534. http://dx.doi.org/10.1159/000321319
14. Adamczak M, Wiecek A. The Adipose Tissue as an Endocrine Organ. Semin Nephrol 2013; 33(1):2-13. PMID:23374889. http://dx.doi.org/10.1016/j.semnephrol.2012.12.008
15. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB. Adiposeselective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001; 409 (6821):729-33. PMID:11217863. http://dx.doi.org/10.1038/35055575
16. Marra F, Bertolani C. Adipokines in liver disease. Hepatology 2009; 50:957-69. PMID:19585655. http://dx.doi.org/10.1002/hep.23046
17. Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism. part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. DiabetesMetab 2008; 34:317-27. PMID:18550411. http://dx.doi.org/10.1016/j.diabet.2008.04.001
18. Cusi K. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep 2010; 10:306-15. PMID:20556549. http://dx.doi.org/10.1007/s11892-010-0122-6
19. Wree A, Kahraman A, Gerken G, Canbay A. Obesity affects the liver: the link between adipocytes and hepatocytes. Digestion 2011; 83:124-33. PMID:21042023. http://dx.doi.org/10.1159/000318741
20. Lu Y, Cederbaum AI. CYP2E1 and Oxidative Liver Injury by Alcohol. Free Radic. Biol. Med. 2008; 44 (5):723-38. PMID:18078827. http://dx.doi.org/10.1016/j.freeradbiomed.2007.11.004
21. Kang L, Chen X, Sebastian BM, Pratt BT, Bederman IR, Alexander JC, Previs SF, Nagy LE. Chronic ethanol and triglyceride turnover in white adipose tissue in rats: inhibition of the anti-lipolytic action of insulin after chronic ethanol contributes to increased triglyceride degradation. J Biol Chem 2007; 282:28465-73. PMID:17686776. http://dx.doi.org/10.1074/jbc.M705503200
22. Chen X, Sebastian BM, Nagy LE. Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. Am J Physiol Endocrinol Metab 2007; 292: E621-E628. PMID:17047161. http://dx.doi.org/10.1152/ajpendo.00387.2006
23. Sebastian BM, Roychowdhury S, Tang H, Hillian AD, Feldstein AE, Stahl GL, Takahashi K, Nagy LE. Identification of a cytochrome P4502E1/Bid/C1q-dependent axis mediating inflammation in adipose tissue after chronic ethanol feeding to mice. J Biol Chem. 2011; 286(41):35989-97. PMID:21856753. http://dx.doi.org/10.1074/jbc.M111.254201
24. Barnes MA, Roychowdhury S, Nagy LE. Innate immunity and cell death in alcoholic liver disease: Role of cytochrome P4502E1. Redox Biology 2014; 2:929-35. PMID:25180169. http://dx.doi.org/10.1016/j.redox.2014.07.007
25. Kumagi T, Akbar F, Horiike N, Onji M. Increases serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues. Clinical Biochemistry 2001; 34:189-93. PMID:11408016. http://dx.doi.org/10.1016/S0009-9120(01)00214-4
26. Barnes MA, McMullen MR, Roychowdhury S, Pisano SG, Liu X, Stavitsky AB, Bucala R, Nagy LE. Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis. Hepatology 2013; 57:1980-91. PMID:23174952. http://dx.doi.org/10.1002/hep.26169
27. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372 (6505):425-32. PMID:7984236. http://dx.doi.org/10.1038/372425a0
28. Kang K. White adipose tissue as an endocrine organ. MA Shiffman (Ed.), Autologous Fat Transfer, Springer-Verlag Berlin Heidelberg; 2010:37-40.
29. Morash B, Li A, Murphy PR, Wilkinson M, Ur E (1999). Leptin gene expression in the brain and pituitary glands. Endocrinology, 140, 5995-8. PMID:10579368. http://dx.doi.org/10.1210/endo.140.12.7288
30. Yura S, Sagawa N, Itoh H, Kakui K, Nuamah MA, Korita D, Takemura M, Fujii S. Resistin is expressed in the human placenta. J Clin Endocrinol Metab 2003; 88:1394-7. PMID:12629135. http://dx.doi.org/10.1210/jc.2002-011926
31. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 2001; 285:561-4. PMID:11444881. http://dx.doi.org/10.1006/bbrc.2001.5173
32. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O’Rahilly S. Resistin/FIZZ3 expression in relation to obesity and peroxisome-proliferator activated receptor-gamma action in humans. Diabetes 2001; 50:2199-02. PMID:11574398. http://dx.doi.org/10.2337/diabetes.50.10.2199
33. Baker SS, Baker RD, Liu W, Nowak NJ, Zhu L. Role of alcohol metabolism in non-alcoholic steatohepatitis. PLoS One 2010; 5: e9570. PMID:20221393. http://dx.doi.org/10.1371/journal.pone.0009570
34. Kang L Sebastian BM Pritchard MT Pratt BT Previs SF Nagy LE. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Alcohol Clin Exp Res 2007; 31(9):1581-8. PMID:17624994. http://dx.doi.org/10.1111/j.1530-0277.2007.00452.x
35. Kang X, Zhong W, Liu J, Song Z, McClain CJ, Kang YJ, Zhou Z. Zinc supplementation reverses alcoholinduced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferatoractivated receptor-alpha. Hepatology 2009; 50:1241-50. PMID:19637192. http://dx.doi.org/10.1002/hep.23090
36. Zhou SL, Gordon RE, Bradbury M, Stump D, Kiang CL, Berk PD. Ethanol up-regulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells. Hepatology 1998; 27:1064-74. PMID:9537447. http://dx.doi.org/10.1002/hep.510270423
37. Berk PD, Zhou S, Bradbury MW (2005). Increased hepatocellular uptake of long chain fatty acids occurs by different mechanisms in fatty livers due to obesity or excess ethanol use, contributing to development of steatohepatitis in both settings. Trans Am Clin Climatol Assoc 2005; 116:335-44. PMID:16555625
38. Rachdaoui N, Sebastian BM, Nagy LE. Chronic ethanol feeding impairs endothelin-1-stimulated glucose uptake via decreased G alpha 11 expression in rat adipocytes. Am J Physiol-Endocr M. 2003; 285: E303-10
39. Wei X, Shi X, Zhong W, Zhao Y, Tang Y, Sun W, Yin X, Bogdanov B, Kim S, McClain C, et al. Chronic alcohol exposure disturbs lipid homeostasis at the adipose tissue-liver axis in mice: analysis of triacylglycerols using high-resolution mass spectrometry in combination with In vivo metabolite deuterium labeling. PLoS ONE 2013; 8(2):1-10
40. Zhong W, Zhao Y, Tang Y, Wei X, Shi X, Sun W, Sun X, Yin X, Sun X, Kim S, et al. Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol 2012; 180:998-1007. PMID:22234172. http://dx.doi.org/10.1016/j.ajpath.2011.11.017
41. Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P, Tornqvist H, Zechner R, Zimmermann R. Adipose triglyceride lipase and hormonesensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 2006; 281:40236-41. PMID:17074755. http://dx.doi.org/10.1074/jbc.M608048200
42. Anthonsen MW, Ronnstrand L, Wernstedt C, Degerman E, Holm C. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem 1998; 273:215-21. PMID:9417067. http://dx.doi.org/10.1074/jbc.273.1.215
43. Wood SL, Emmison N, Borthwick AC, Yeaman SJ. The protein phosphatases responsible for dephosphorylation of hormone-sensitive lipase in isolated rat adipocytes. Biochem J 1993; 295:531-5. PMID:8240253
44. Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001; 353:417-39. PMID:11171037. http://dx.doi.org/10.1042/0264-6021:3530417
45. Dou X, Xia Y, Chen J, Qian Y, Li S, Zhang X, Song Z. Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease. Br J Pharmacol 2014; 171(17):4073-86. PMID:24819676. http://dx.doi.org/10.1111/bph.12765
46. Addolorato G, Capristo E, Greco AV, Stefanini GF, Gasbarrini G. Energy expenditure, substrate oxidation, and body composition in subjects with chronic alcoholism: new findings from metabolic assessment. Alcohol Clin Exp Res 1997; 21:962-7. PMID:9309302
47. Addolorato G, Capristo E, Greco AV, Stefanini GF, Gasbarrini G. Influence of chronic alcohol abuse on body weight and energy metabolism: is excess ethanol consumption a risk factor for obesity or malnutrition? J Intern Med 1998; 244:387-95. PMID:9845854. http://dx.doi.org/10.1046/j.1365-2796.1998.00381.x
48. Addolorato G, Capristo E, Marini M, Santini P, Scognamiglio U, Attilia ML, Messineo D, Sasso GF, Gasbarrini G, Ceccanti M. Body composition changes induced by chronic ethanol abuse: evaluation by dual energy X-ray absorptiometry. Am J Gastroenterol 2000; 95:2323-7. PMID:11007236. http://dx.doi.org/10.1111/j.1572-0241.2000.02320.x
49. Leggio L, Malandrino N, Ferrulli A, Cardone S, Miceli A, Gasbarrini G, Capristo E, Addolorato G. Is cortisol involved in the alcohol-related fat mass impairment? A longitudinal clinical study. Alcohol Alcohol 2009; 44:211-5. PMID:19144979. http://dx.doi.org/10.1093/alcalc/agn116
50. Krsek M, Ruziicka M, Nedvidkova J, Kvasnickova H, Hana V, Marek J, Haluzik M, Lai EW, Pacak K. Increased lipolysis of subcutaneous abdominal adipose tissue and altered noradrenergic activity in patients with Cushing’s syndrome: an in-vivo microdialysis study. Physiol Res 2006; 55:421-8. PMID:16238457
51. Unger RH. The physiology of cellular liporegulation. Annu Rev Physiol 2003; 65:333-47. PMID:12471167. http://dx.doi.org/10.1146/annurev.physiol.65.092101.142622
52. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116:39-48. PMID:17576866. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.675355
53. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21:697-738. PMID:11133069. http://dx.doi.org/10.1210/edrv.21.6.0415
54. Matsushita Y, Nakagawa T, Yamamoto S, Takahashi Y, Yokoyama T, Noda M, Mizoue T. Associations of visceral and subcutaneous fat areas with the prevalence of metabolic risk factor clustering in 6,292 Japanese individuals: the Hitachi Health Study. Diabetes Care 2010; 33:2117-9. PMID:20460443. http://dx.doi.org/10.2337/dc10-0120
55. Molenaar EA, Massaro JM, Jacques PF, Pou KM, Ellison RC, Hoffmann U, Pencina K, Shadwick SD, Vasan RS, et al. Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: The Framingham Heart Study. Diabetes Care 2009; 32:505-10. PMID:19074991. http://dx.doi.org/10.2337/dc08-1382
56. Suter PM, Hasler E, Vetter W. Effects of alcohol on energy metabolism and body weight regulation: is alcohol a risk factor for obesity? Nutr Rev 1997; 55: 157-71. PMID:9212692. http://dx.doi.org/10.1111/j.1753-4887.1997.tb06470.x
57. Westerterp-Plantenga MS, Verwegen CR. The appetizing effect of an aperitif in over-weight and normalweight humans. Am J Clin Nutr 1999; 69:205-12. PMID:9989681
58. Kim KH, Oh SW, Kwon H, Park JH, Choi H, Cho B. Alcohol Consumption and Its Relation to Visceral and Subcutaneous Adipose Tissues in Healthy Male Koreans. AnnNutrMetab 2012; 60:52-61. PMID:22327000
59. Mathurin P, Deng QG, Keshavarzian A, Choudhary S, Holmes E.W, Exacerbation of alcoholic liver by enteral endotoxin in rat. Hepatology 2000; 32:1008-17. PMID:11050051. http://dx.doi.org/10.1053/jhep.2000.19621
60. Tamai H, Kato S, Horie Y, Ohki E, Yokoyama H, Ishii H. Effect of ethanol administration on the intestinal absorption of endotoxin in rat. Alcohol. Clin. Exp.Res 2000; 24:390-4. PMID:10776683. http://dx.doi.org/10.1111/j.1530-0277.2000.tb04629.x
61. Jarvelainen HA, Fang C, Ingelmann-Sundberg M, Lindros KO. Effect of chronic coadministration of endotoxin and ethanol onrat liver pathology and proinflammatory and anti-inflammatory cytokines. Hepatology 1999; 29:1503-10. PMID:10216135. http://dx.doi.org/10.1002/hep.510290508
62. Mandal P, Park PH, McMullen MR, Pratt BT, Nagy LE. The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells. Hepatology 2010; 51(4):1420-9. PMID:20052772. http://dx.doi.org/10.1002/hep.23427
63. Mandal P, Pritchard MT, Nagy LE. Anti-inflammatory pathways and alcoholic liver disease: Role of an adiponectin/ interleukin-10/heme oxygenase-1 pathway. World J Gastroenterol 2010; 16(11):1330-6. PMID:20238399. http://dx.doi.org/10.3748/wjg.v16.i11.1330
64. Nicolas JM, Fernandez-Sola J, Fatjo F, Casamitjana R, Bataller R, Sacanella E, Tobıas E, Badıa E, Estruch R. Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res 2001; 25:83-88. PMID:11198718. http://dx.doi.org/10.1111/j.1530-0277.2001.tb02130.x
65. Tang H, Sebastian BM, Axhemi A, Chen X, Hillian AD, Jacobsen DW, Nagy LE. Ethanol-induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes. Alcohol Clin Exp Res 2012; 36:214-22. PMID:21895711. http://dx.doi.org/10.1111/j.1530-0277.2011.01607.x
66. Qin Y, Hamilton JL, Bird MD, Chen MM, Ramirez L, Zahs A, Kovacs EJ, Makowski L. Adipose inflammation and macrophage infiltration after binge ethanol and burn injury. Alcohol Clin Exp Res 2013; 38:204-13. PMID:23909743. http://dx.doi.org/10.1111/acer.12210
67. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29:2959-71. PMID:18775919. http://dx.doi.org/10.1093/eurheartj/ehn387
68. Klatsky AL, Udaltsova N. Alcohol drinking and total mortality risk. Ann. Epidemiol 2007; 17(5): S63-S67. http://dx.doi.org/10.1016/j.annepidem.2007.01.014
69. Syapin PJ, Militante JD, Garrett DK, Ren L. Cytokineinduced iNOS expression in C6 glial cells: transcriptional inhibition by ethanol. J Pharmacol Exp Ther 2001; 298(2):744-52. PMID:11454939
70. Nanji A, Miao A.L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, Peters D, Tahan SR, Dannenberg AJ. Enhanced cyclooxygenase-2 g ene expression in alcoholic liver disease in the rat. Gastroenterology 1997; 112(3):943-51. PMID:9041257. http://dx.doi.org/10.1053/gast.1997.v112.pm9041257
71. Yuan G J, Zhou X R, Gong Z J, Zhang P, Sun X M, Zheng S H. Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury.World J. Gastroenterol 2006; 12(15):2375-81. PMID:16688828D
72. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003; 112:91-100. PMID:12840063. http://dx.doi.org/10.1172/JCI200317797
73. You M, Considine RV, Leone TC, Kelly DP, Crabb DW. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 2005; 42:568-77. PMID:16108051. http://dx.doi.org/10.1002/hep.20821
74. Esfandiari F, You M, Villanueva JA, Wong DH, French SW, Halsted CH. S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet. Alcohol Clin Exp Res 2007; 31:1231-39. PMID:17577393. http://dx.doi.org/10.1111/j.1530-0277.2007.00407.x
75. Song Z, Zhou Z, Deaciuc I, Chen T, McClain CJ. Inhibition of adiponectin production by homocysteine: potential mechanism for alcoholic liver disease. Hepatology 2008; 47:867-79. PMID:18167065. http://dx.doi.org/10.1002/hep.22074
76. Shen Z, Liang X, Rogers CQ, Rideout D, You M. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2010; 298: G364-G374. PMID:20007851. http://dx.doi.org/10.1152/ajpgi.00456.2009
77. Otaka M, Konishi N, Odashima M, Jin M, Wada I, Matsuhashi T, Ohba R, Watanabe S. Effect of alcohol consumption on leptin level in serum, adipose tissue, and gastric mucosa. Dig Dis Sci 2007; 52:3066-9. PMID:17406835. http://dx.doi.org/10.1007/s10620-006-9635-x
78. Maddalozzo GF, Turner RT, Edwards CH, Howe KS, Widrick JJ, Rosen CJ, Iwaniec UT. Alcohol alters whole body composition, inhibits bone formation, and increases bone marrow adiposity in rats. Osteoporos Int 2009; 20:1529-38. PMID:19238309. http://dx.doi.org/10.1007/s00198-009-0836-y
79. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316: 129-39. PMID:19723556. http://dx.doi.org/10.1016/j.mce.2009.08.018
80. Ajmo JM, Liang X, Rogers CQ, Pennock B, You M. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2008; 295: G833-G842. PMID:18755807. http://dx.doi.org/10.1152/ajpgi.90358.2008
81. Sun X, Tang Y, Tan X, Li Q, Zhong W, Sun X, Jia W, McClain CJ, Zhou Z. Activation of peroxisome proliferator-activated receptor-g by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice. Am J Physiol Gastrointest Liver Physiol 2012; 302: G548-G557. PMID:22173916. http://dx.doi.org/10.1152/ajpgi.00342.2011
82. Greco AV, Mingrone G, Favuzzi A, Capristo E, Gniuli D, Addolorato G, Brunani A, Cavagnin F, Gasbarrini G. Serum leptin levels in post-hepatitis liver cirrhosis. J Hepatol 2000; 33:38-42. PMID:10905584. http://dx.doi.org/10.1016/S0168-8278(00)80157-9
83. Santolaria F, Perez-Cejas A, Aleman MR, Gonzalez-Reimers E, Milena A, de la Vega MJ, Martınez-Riera A, Gomez-Rodrıguez MA. Low serum leptin levels and malnutrition in chronic alcohol misusers hospitalized by somatic complications. Alcohol Alcohol 2003; 38:60-6. PMID:12554610. http://dx.doi.org/10.1093/alcalc/agg015
84. Calissendorff J, Brismar K, Rojdmark S. Is decreased leptin secretion after alcohol ingestion catecholaminemediated? Alcohol Alcohol 2004; 39:281-6. PMID:15208157. http://dx.doi.org/10.1093/alcalc/agh054
85. Kalousova M, Zima T, Popov P, Spacek P, Braun M, Soukupova J, Pelinkova K, Kientsch-Engel R. Advanced glycation end-products in patients with chronic alcohol misuse. Alcohol Alcohol 2004; 39:316-20. PMID:15208163. http://dx.doi.org/10.1093/alcalc/agh058
86. Ren RZ, Zhang X, Xu J, Zhang HG, Yu CX, Cao MF, Gao L, Guan QB, Zhao JJ. Chronic ethanol consumption increases the levels of chemerin in the serum and adipose tissue of humans and rats. Acta Pharmacologica Sinica 2012; 33:652-9. PMID:22447224. http://dx.doi.org/10.1038/aps.2012.11
87. Yu HC, Li SY, Cao MF, Jiang XY, Feng F, Zhao JJ, Gao L. Effects of chronic ethanol consumption on levels of adipokines in visceral adipose tissues and sera of rats. Acta Pharmacologica Sinica 2010; 31:461-9. PMID:20208553. http://dx.doi.org/10.1038/aps.2010.12
88. Kiselova-Kaneva YO, Tasinov D, Vankova DI. Ethanol induces il-6 and tnf-a cytokine and inos and cox-2 enzyme gene expression in 3t3-l1 preadipocytes, Scripta Scientifica Medica 2012; 44 (2):31-5. http://dx.doi.org/10.14748/ssm.v44i2.354
89. Kasztelan-Szczerbinska B, Surdacka A, Slomka M, Rolinski J, Celinski K, Smolen A, Szczerbinski M. Association of serum adiponectin, leptin, and resistin concentrations with the severity of liver dysfunction and the disease complications in alcoholic liver disease. Mediators Inflammat 2013; 2013; Article ID 148526:12; 24259947
90. Behre CJ. Adiponectin: saving the starved and the overfed. Medical Hypotheses 2007; 69(6):1290-2. PMID:17509773. http://dx.doi.org/10.1016/j.mehy.2007.02.044]
91. Beulens JWJ, de Zoete EC, Kok FJ, Schaafsma G, Hendriks HFJ. Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study. Eur J Clin Nutrit 2008; 62:1098-05. PMID:17554246. http://dx.doi.org/10.1038/sj.ejcn.1602821
92. Naveau S, Cassard-Doulcier AM, Njike-Nakseu M, 20399524 Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease. J Hepatol 2010; 52:895-902. PMID:20399524. http://dx.doi.org/10.1016/j.jhep.2010.01.029
93. Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, Rosenthal-Allieri MA, Agostini H, Njike M, Barri-Ova N, Naveau S, et al. The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One 2012; 7: e35612. PMID:22530059. http://dx.doi.org/10.1371/journal.pone.0035612
94. Voican CS, Njike-Nakseu M, Boujedidi H, Barri-Ova N, Bouchet-Delbos L, Agostini H, Maitre S, Prevot A, Cassard-Doulcier AM, Naveau S, et al. Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease. Liver Int 2014. PMID:24766056. http://dx.doi.org/10.1111/liv.12575
95. Wandler A, Bruun JM, Nielsen MP, Richelsen B. Ethanol exerts anti-inflammatory effects in human adipose tissue in vitro. Mol Cell Endocrinol 2008; 296:26-31. PMID:18840498. http://dx.doi.org/10.1016/j.mce.2008.09.006
96. Pravdova E, Fickova M Alcohol intake modulates hormonal activity of adipose tissue. Endocr Regul 2006; 40(3):91-104. PMID:17100551
97. Wurst FM, Rasmussen DD, Hillemacher T, Kraus T, Ramskogler K, Lesch O, Bayerlein K, Schanze A, Wilhelm J, Junghanns K, et al Alcoholism, craving, and hormones: the role of leptin, ghrelin, prolactin, and the pro-opiomelanocortin system in modulating ethanol intake. Alcohol Clin Exp Res 2007; 31(12):1963-7. PMID:18034691. http://dx.doi.org/10.1111/j.1530-0277.2007.00531.x
98. Hillemacher T., Weinland C., Heberlein A., Groschl M., Schanze A., Frieling H., Wilhelm J., Kornhuber J., Bleich S. Increased levels of adiponectin and resistin in alcohol dependence–possible link to craving. Drug Alcohol Depend 2009; 99(1-3): 333-33. PMID:18818026. http://dx.doi.org/10.1016/j.drugalcdep.2008.07.019